ANDA 86889, held by Watson Labs. Disulfiram.
As of Nov 16, 2026, ANDA 86889 (Disulfiram), held by Watson Labs, was first approved by FDA on Mar 31, 1981, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Disulfiram250MG ยท tablet;oral | Disulfiram | Discontinued |
| Apr 14, 1998 | Supplement 21Labeling | Approved | None posted |
| May 13, 1992 | Supplement 20Manufacturing | Approved | None posted |
| May 31, 1991 | Supplement 17Manufacturing | Approved | None posted |
| Jan 28, 1991 | Supplement 18Manufacturing | Approved | None posted |
| Jun 29, 1990 | Supplement 16Manufacturing | Approved | None posted |
| Feb 27, 1990 | Supplement 19Manufacturing | Approved | None posted |
| Apr 3, 1989 | Supplement 13Manufacturing | Approved | None posted |
| Apr 3, 1989 | Supplement 14Manufacturing | Approved | None posted |
| Apr 12, 1985 | Supplement 10Manufacturing | Approved | None posted |
| Apr 12, 1985 | Supplement 11Manufacturing | Approved | None posted |
| May 26, 1982 | Supplement 7Manufacturing | Approved | None posted |
| Mar 31, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters